Eyewire News

Featured Story

Lenz Therapeutics Announces Major Restructuring and CEO Transition image

10.30.2026

Lenz Therapeutics Announces Major Restructuring and CEO Transition

Lenz Therapeutics announced a major strategic reorganization and CEO transition designed to reduce operating expenses and prioritize consumer marketing for its presbyopia treatment. The reorganization, announced during the company's third-quarter earnings, comes as the company reported a 50% increase in third-quarter 2026 sales of its presbyopia drop Vizz (aceclidine ophthalmic solution 1.44%).

Read Story

Latest News Stories

Octant Receives FDA Orphan Drug Designation for OCT-980 for the Treatment of Retinitis Pigmentosa image

10.30.2026

Octant Receives FDA Orphan Drug Designation for OCT-980 for the Treatment of Retinitis Pigmentosa

VisioSurgical Solutions Launches, Starts Development of Compact Surgical Robot for Retinal Surgery image

10.30.2026

VisioSurgical Solutions Begins Development of Compact Surgical Robot for Retinal Surgery

Oculis to Present Privosegtor Data at Upcoming Ophthalmology and Neurology Conferences image

10.29.2026

Oculis to Present Privosegtor Data at Upcoming Ophthalmology and Neurology Conferences

Kiora Plans Phase 3 CRAO and Phase 2b NAION Trials of KIO-401 image

10.29.2026

Kiora Plans Multinational Phase 3 CRAO and Phase 2b NAION Trials of KIO-401

10.29.2026

Tarsus Pharmaceuticals Names Neera Clase as CCO

10.28.2026

Centre for Sight Founder Sheraz Daya, MD, Receives AAO Lifetime Achievement Honor Award

10.28.2026

Nacuity Pharmaceuticals Doses First Patient in Phase 3 Trial of NPI-001 for the Treatment of RP Associated with Usher Syndrome

10.28.2026

University of Waterloo Research Reveals Guttata-Like Structures Contribute to Corneal Cell Loss

10.27.2026

Nasal Spray Improves Tear Film Stability and DED Symptoms

10.27.2026

Glaukos Announces License Agreement with RevOpsis Therapeutics for Retinal Therapy

Medicare Payment for Balance Ophthalmics’ FSYX image

10.27.2026

Medicare Payment for Balance Ophthalmics’ FSYX

10.26.2026

Research Identifies Previously Unrecognized Outflow Pathway

Study Evaluates Sierra Leone’s Cataract Outreach Program image

10.26.2026

Study Evaluates Sierra Leone’s Cataract Outreach Program

Bronwyn Brophy O’Connor to Become CEO of Carl Zeiss Meditec Group image

10.26.2026

Bronwyn Brophy O’Connor to Become CEO of Carl Zeiss Meditec Group

10.23.2026

Siloton Secures £8.4 Million Innovate UK Contract to Accelerate Development of Handheld OCT Technology

10.23.2026

CHMP Recommends European Approval of Fovlussea, a Ranibizumab Biosimilar, for Retinal Diseases

Zeiss Announces Commercial Availability of CT Lucia 621P Monofocal IOL in Japan image

10.22.2026

Zeiss Announces Commercial Availability of CT Lucia 621P Monofocal IOL in Japan

10.22.2026

Newton Registry Finds Only 12.2% of Glaucoma Patients Undergo Procedural Treatment

10.22.2026

FDA Clears Opus Genetics' IND Application for OPGx-RDH12 Gene Therapy in Leber Congenital Amaurosis

View More

EyewireTV

Eyewire TV October 28, 2026 thumbnail

10.28.2026

The Latest EyewireTV

Alcon

Johnson & Johnson

Zeiss

Watch Episode

Watch the Latest Episode

Stay Updated

Sign up for Eyewire News and EyewireTV e‑newsletters to stay up to date on news in eye care!

Subscribe